Suomi -
suomi -
Fimea (Suomen lääkevirasto)
levomethadone g.l. pharma 10 mg tabletti
g.l. pharma gmbh - levomethadone hydrochloride - tabletti - 10 mg - levometadoni
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
levomethadone g.l. pharma 20 mg tabletti
g.l. pharma gmbh - levomethadone hydrochloride - tabletti - 20 mg - levometadoni
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
levomethadone g.l. pharma 30 mg tabletti
g.l. pharma gmbh - levomethadone hydrochloride - tabletti - 30 mg - levometadoni
Euroopan unioni -
suomi -
EMA (European Medicines Agency)
phesgo
roche registration gmbh - pertuzumab, trastuzumab - rintojen kasvaimet - antineoplastiset aineet - early breast cancer (ebc)phesgo is indicated for use in combination with chemotherapy in:the neoadjuvant treatment of adult patients with her2-positive, locally advanced, inflammatory, or early stage breast cancer at high risk of recurrencethe adjuvant treatment of adult patients with her2-positive early breast cancer at high risk of recurrencemetastatic breast cancer (mbc)phesgo is indicated for use in combination with docetaxel in adult patients with her2-positive metastatic or locally recurrent unresectable breast cancer, who have not received previous anti-her2 therapy or chemotherapy for their metastatic disease.
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
amoxin 500 mg tabletti, kalvopäällysteinen
ratiopharm gmbh - amoxicillin trihydrate - tabletti, kalvopäällysteinen - 500 mg - amoksisilliini
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
amoxin 750 mg tabletti, kalvopäällysteinen
ratiopharm gmbh - amoxicillin trihydrate - tabletti, kalvopäällysteinen - 750 mg - amoksisilliini
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
amoxin 100 mg/ml jauhe oraalisuspensiota varten
ratiopharm gmbh - amoxicillin trihydrate - jauhe oraalisuspensiota varten - 100 mg/ml - amoksisilliini
Euroopan unioni -
suomi -
EMA (European Medicines Agency)
lunsumio
roche registration gmbh - mosunetuzumab - lymfooma, follicular - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.
Euroopan unioni -
suomi -
EMA (European Medicines Agency)
columvi
roche registration gmbh - glofitamab - lymphoma, large b-cell, diffuse - antineoplastiset aineet - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.
Suomi -
suomi -
Fimea (Suomen lääkevirasto)
amoxicillin mip pharma 500 mg tabletti
mip pharma gmbh - amoxicillin trihydrate - tabletti - 500 mg - amoksisilliini